Literature DB >> 25249804

Calcific uremic arteriolopathy in end stage renal disease: pathophysiology and management.

Preethi Yerram1, Kunal Chaudhary2.   

Abstract

BACKGROUND: Calcific uremic arteriolopathy (CUA), a debilitating condition with high morbidity and mortality, is most commonly seen in patients with kidney disease. The pathophysiology of CUA is multifactorial, leading to a disruption in the balance between factors that promote and those that inhibit calcification, although the exact pathophysiological mechanisms of CUA remain to be elucidated.
METHODS: This review provides an overview of the pathophysiology, clinical presentation and diagnosis, and treatment of CUA.
RESULTS: Diagnosis of CUA requires a high degree of suspicion; skin biopsy with histological examination remains the gold standard to confirm the diagnosis. Treatment of CUA requires a multidisciplinary approach.
CONCLUSION: With a high degree of clinical suspicion and early diagnosis, an aggressive multifactorial treatment approach involving optimal wound management, minimization/avoidance of risk factors and precipitating causes, and correction of calcium-phosphorus abnormalities can significantly improve patient outcomes.

Entities:  

Keywords:  Calciphylaxis; hyperparathyroidism; sodium thiosulfate; vascular calcification; wound healing

Year:  2014        PMID: 25249804      PMCID: PMC4171796     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  50 in total

1.  Successful treatment of calciphylaxis with intravenous sodium thiosulfate.

Authors:  Jeffrey S Cicone; John B Petronis; Carmen D Embert; David A Spector
Journal:  Am J Kidney Dis       Date:  2004-06       Impact factor: 8.860

2.  Low-dose tissue plasminogen activator for calciphylaxis.

Authors:  Lindsay D Sewell; Roger H Weenig; Mark D P Davis; Marian T McEvoy; Mark R Pittelkow
Journal:  Arch Dermatol       Date:  2004-09

3.  Calciphylaxis: natural history, risk factor analysis, and outcome.

Authors:  Roger H Weenig; Lindsay D Sewell; Mark D P Davis; James T McCarthy; Mark R Pittelkow
Journal:  J Am Acad Dermatol       Date:  2006-12-01       Impact factor: 11.527

Review 4.  Calcific uremic arteriolopathy: advances in pathogenesis and treatment.

Authors:  Natasha M Rogers; David J O Teubner; P Toby H Coates
Journal:  Semin Dial       Date:  2007 Mar-Apr       Impact factor: 3.455

Review 5.  Inhibitors of calcification in blood and urine.

Authors:  Georg Schlieper; Ralf Westenfeld; Vincent Brandenburg; Markus Ketteler
Journal:  Semin Dial       Date:  2007 Mar-Apr       Impact factor: 3.455

6.  Multi-intervention management of calciphylaxis: a report of 7 cases.

Authors:  Corisande Baldwin; Myriam Farah; Marianna Leung; Paul Taylor; Ronald Werb; Mercedeh Kiaii; Adeera Levin
Journal:  Am J Kidney Dis       Date:  2011-08-26       Impact factor: 8.860

7.  Calciphylaxis in patients on hemodialysis: a prevalence study.

Authors:  M Angelis; L L Wong; S A Myers; L M Wong
Journal:  Surgery       Date:  1997-12       Impact factor: 3.982

8.  Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis.

Authors:  Colette B Raymond; Lori D Wazny
Journal:  Am J Health Syst Pharm       Date:  2008-08-01       Impact factor: 2.637

9.  Calcific uremic arteriolopathy in peritoneal dialysis populations.

Authors:  Nicholas New; Janaki Mohandas; George T John; Sharad Ratanjee; Helen Healy; Leo Francis; Dwarakanathan Ranganathan
Journal:  Int J Nephrol       Date:  2011-06-27

10.  Hyperbaric oxygen as effective adjuvant therapy in the treatmentof distal calcific uraemic arteriolopathy.

Authors:  Natasha M Rogers; Sean H Chang; David J O Teubner; Patrick T H Coates
Journal:  NDT Plus       Date:  2008-05-13
View more
  6 in total

1.  Metabolic acidosis status and mortality in patients on the end stage of renal disease.

Authors:  Vaia D Raikou
Journal:  J Transl Int Med       Date:  2016-12-30

2.  Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study.

Authors:  Murray Baron; Janet Pope; David Robinson; Niall Jones; Nader Khalidi; Peter Docherty; Elzbieta Kaminska; Ariel Masetto; Evelyn Sutton; Jean-Pierre Mathieu; Sophie Ligier; Tamara Grodzicky; Sharon LeClercq; Carter Thorne; Geneviève Gyger; Douglas Smith; Paul R Fortin; Maggie Larché; Maysan Abu-Hakima; Tatiana S Rodriguez-Reyna; Antonio R Cabral-Castaneda; Marvin J Fritzler; Mianbo Wang; Marie Hudson
Journal:  Rheumatology (Oxford)       Date:  2016-09-04       Impact factor: 7.580

3.  Non-uraemic calciphylaxis (NUC) postliver transplantation.

Authors:  Simona Frunza-Stefan; Silpa Poola-Kella; Kristi Silver
Journal:  BMJ Case Rep       Date:  2018-10-24

Review 4.  POEMS syndrome and calciphylaxis: an unrecognized cause of abnormal small vessel calcification.

Authors:  Nobuyuki Araki; Sonoko Misawa; Kazumoto Shibuya; Satoshi Ota; Takashi Oide; Asuka Kawano; Minako Beppu; Yukio Nakatani; Satoshi Kuwabara
Journal:  Orphanet J Rare Dis       Date:  2016-04-12       Impact factor: 4.123

5.  Gastrointestinal Bleeding Secondary to Calciphylaxis.

Authors:  Nancy Gupta; Khwaja F Haq; Sugandhi Mahajan; Prashant Nagpal; Bijal Doshi
Journal:  Am J Case Rep       Date:  2015-11-17

6.  Gastric Pneumatosis from Isolated Gastric Calciphylaxis.

Authors:  Aditi Mulgund; Sanam Razeghi; Sampath Poreddy
Journal:  ACG Case Rep J       Date:  2017-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.